神經修復術市場規模、佔有率、成長分析，按類型、技術、應用、地區分類 - 產業預測，2024-2031 年

Neuroprosthetics Market Size, Share, Growth Analysis, By Type, By Technique, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月06日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球神經修復市場規模為103億美元，從2023年的115.9億美元成長到2031年的297.3億美元，複合年成長率預計為12.50%。

神經系統疾病盛行率的上升以及對具有成本效益和技術先進的植入的需求不斷成長預計將在未來幾年推動全球神經假體市場的成長。此外，老年人口的增加和聽力障礙、癲癇、阿茲海默症和嚴重憂鬱症等疾病發病率的增加進一步促進了市場的擴張。隨著對改進治療的需求增加，預計全球對神經修復解決方案的需求將會增加。聽力損失病例的顯著增加也在市場成長中發揮重要作用。助聽器和人工電子耳等設備對於解決這些問題至關重要。根據世界衛生組織（WHO）預測，到2031年，全球將有約25億人遭受聽力損失，約7億人需要聽力復健。聽力損失負擔的增加可能會在不久的將來進一步推動對神經修復術的需求。此外，領先公司和政府機構增加對技術進步和研發的投資也有望促進市場成長。例如，2019 年 8 月，MED-EL 的 Synchrony-2人工電子耳系統獲得美國食品藥物管理局的核准，該系統專為單側和不對稱聽力損失患者設計，顯示了該領域的持續創新。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Medtronic（US）
Abbott（US）
Cochlear（Australia）
Boston Scientific（US）
Livanova（UK）
Med-El（Austria）
Sonova（Switzerland）
Neuropace（US）
NDI Medical（Canada）
Nevro（US）
SensArs Neuroprosthetics（Switzerland）
NeuroPace, Inc.（US）
Pixium Vision（France）
NeuroSigma, Inc.（US）
Axonics Modulation Technologies, Inc.（US）
Nervo Corp（US）
Soterix Medical, Inc.（US）
Aleva Neurotherapeutics SA（Switzerland）
Synapse Biomedical, Inc.（US）
Cleveland FES Center（US）

簡介目錄

Product Code: SQMIG35A2517

Global Neuroprosthetics Market size was valued at USD 10.3 billion in 2022 and is poised to grow from USD 11.59 billion in 2023 to USD 29.73 billion by 2031, growing at a CAGR of 12.50% during the forecast period (2024-2031).

The rising prevalence of neurological disorders and the growing demand for cost-effective, technologically advanced implants are anticipated to drive the growth of the global neuroprosthetics market in the coming years. Additionally, the increasing geriatric population and the growing incidence of diseases such as auditory disorders, epilepsy, Alzheimer's, and severe depression are further contributing to the market's expansion. As the need for improved treatments grows, the demand for neuroprosthetic solutions is expected to rise globally. The significant increase in hearing loss cases also plays a key role in market growth. Devices like hearing aids and cochlear implants are crucial in addressing these issues. According to the World Health Organization, by 2031, approximately 2.5 billion people worldwide are projected to suffer from hearing loss, with around 700 million expected to require hearing rehabilitation. This growing burden of hearing impairment is likely to further boost demand for neuroprosthetics in the near future. Technological advancements and increased investment in research and development by major companies and government organizations are also expected to fuel market growth. For example, in August 2019, MED-EL received approval from the U.S. Food & Drug Administration for its Synchrony-2 Cochlear Implant System, designed for patients with single-sided deafness and asymmetric hearing loss, illustrating the continuous innovation driving the sector forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuroprosthetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuroprosthetics Market Segmental Analysis

Global Neuroprosthetics Market is segmented by Type, Technique, Application, and region. Based on Type, the market is segmented into Output Neural Prosthetics, Neural Prosthetic. Based on Technique, the market is segmented into Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Transcranial Magnetic Stimulation. Based on Application, the market is segmented into Motor Neuron Disorders, Physiological Disorders, and Cognitive Disorders. Based on end user, the market is segmented into automotive, consumer electronics, healthcare, agriculture, manufacturing, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Neuroprosthetics Market

The high prevalence of neurological disorders and nerve-related injuries is expected to be a significant driver for the global neuroprosthetics market during the forecast period. For instance, neurological diseases have led to more than 533,000 deaths, with around 213,000 males and 320,000 females affected. Neuroprosthetic devices offer numerous benefits, making them essential in the treatment of such conditions. These devices, such as cochlear implants and auditory brainstem implants (ABI), are particularly beneficial for patients with hearing impairments. As a result, the global demand for neuroprosthetics in diagnosing and treating various neurological disorders is expected to fuel market growth in the coming years. The increasing recognition of the advantages of these devices in improving patient outcomes will likely lead to greater adoption, further propelling the market's expansion.

Restraints in the Global Neuroprosthetics Market

The growing popularity of alternative treatment methods, such as stem cell therapy, is expected to significantly hamper the growth of the neuroprosthetics market during the forecast period. Stem cell therapy provides promising opportunities for treating various neurological conditions, including motor neuron diseases like Parkinson's and Alzheimer's. Its appeal lies in its relatively lower cost compared to neuroprosthetic devices, as well as the simplicity of its treatment regimen, which is attracting more patients toward this alternative option. As a result, the increasing shift toward stem cell treatments is likely to restrain the global expansion of the neuroprosthetics market in the coming years, as patients opt for these cost-effective and less invasive alternatives.

Market Trends of the Global Neuroprosthetics Market

Input neural prosthetics are gaining increasing popularity due to the rising prevalence of hearing loss and technological advancements in the development of various devices. These prosthetics offer significant benefits, such as restoring a sense of sound for individuals who are profoundly deaf or hard of hearing. Their ease of use and relatively low implementation cost make them attractive, creating substantial growth opportunities in the coming years. Research indicates that cochlear implants not only help diagnose hearing loss but are also being recommended as a rehabilitation tool for tinnitus patients suffering from depression. As a result, the neuroprosthetics market is poised for significant growth in the near future, driven by the growing demand for innovative solutions to address hearing loss and other related conditions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Regulatory Analysis
Case Study Analysis

Neuroprosthetics Market by Type

Market Overview
Output Neural Prosthetics
- Motor Prosthetics
- Cognitive Prosthetics
Input Neural Prosthetics
- Cochlear Implants
- Bionic Eye/Retinal Implants

Neuroprosthetics Market by Technique

Market Overview
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Transcranial Magnetic Stimulation

Neuroprosthetics Market by Application

Market Overview
Motor Neuron Disorders
- Parkinson'S Disease
- Epilepsy
Physiological Disorders
- Auditory Processing Disorders
- Ophthalmic Disorders
- Cardiovascular Disorders
- Urology Disorders
Cognitive Disorders
- Alzheimer'S Disease
- Paralysis

Neuroprosthetics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Livanova (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Med-El (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonova (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuropace (U S)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NDI Medical (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SensArs Neuroprosthetics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pixium Vision (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroSigma, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axonics Modulation Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nervo Corp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cleveland FES Center (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments